US Stocks
Neogenomics Inc.
Neogenomics Inc.

Neogenomics Inc. (NEO)


  • $







Key Stats

Today Low/High$45.22 / $46.21
52 Week Low/High$36 / $61.57
P/E ratio76.25
Market Cap$5.58B

Company Details

NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma Services division serves pharmaceutical clients in clinical trials and drug development. Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Ft. Myers and Tampa, Florida; Aliso Viejo, Carlsbad and Fresno California; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.
OrganisationNeogenomics Inc.
HeadquatersFort Myers, Florida, United States
IndustryHealth Services

Discover more

Frequently Asked Questions

What is Neogenomics Inc. (NEO) share price today?

Can Indians buy Neogenomics Inc. (NEO) shares?

How can I buy Neogenomics Inc. (NEO) shares from India?

Can Fractional shares of Neogenomics Inc. (NEO) be purchased?

What are the documents required to start investing in Neogenomics Inc. (NEO) stocks?

We are a SEBI registered investement advisor